|
|
| Company name |
NANOSION Co. Ltd. |
| CEO & President |
Eiki Igarashi |
| Location |
|
| Established date |
September 26, 2008 |
| Business content |
Research and development of nanomedicines and nanoproducts |
| Profile of CEO |
Igarashi experienced the evaluation of efficacy/safety of polymeric nanomedicines
at Nanocarrier Co., Ltd. (see Igarashi, 2008, Toxicol. Appl. Pharmacol., 229:121-134). Before that he experienced as toxicologist and project manager in Hoechst
Marion Roussel K.K. (Sanofi K.K. at present). Recently, he experienced
the biomedical survey of nanoparticles in the National Institute of Advanced
Industrial Science and Technology (AIST)., and then he published a comprehensive
text for all nanoscientists ( see Igarashi 2015. by CRC Press). |
| Mission (business concept) |
Our company is focusing as the mission of business concept to realize
medically high valuable and beneficial new medical care on three categories
of diagnosis, therapy and palliative care of unmet cancer therapeutic area
by traditional technology. |
| Origin of company name |
NANOSION was named by three key words for promising nanomedicine, size,
shape and electric charge. NANO means the size for selectivity with capillary.
S means capital S in sharp. ION means ion for electric charge. |
We are not recruiting any corporate staff nowMedical licensing representative
Responsibility - negotiation with other company for licensing-out or co-development.
Competency - Licensing experience in pharmaceutical company.
Age - Ageless. Also welcome to a person with licensing experience as a second job after retirement.
Applicant should send CV below mail address.
adm@nanosion.com. |
|
|
|
|
